BackMoonLake Immunotherapeutics Overview
MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics Return on Equity

Return on Equity (ROE) for MLTX.

Get informed when a big investor buys or sells

+ Follow

ROE

-101.49%

Return on Equity

-101.49%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading